132 related articles for article (PubMed ID: 16531764)
21. Repression of MLH1 and MGMT genes in colon mucosa adjacent to implanted cancer in athymic mouse.
Kuniyasu H; Sasaki T; Sasahira T; Chihara Y; Ohmori H
J Exp Clin Cancer Res; 2004 Jun; 23(2):317-23. PubMed ID: 15354418
[TBL] [Abstract][Full Text] [Related]
22. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of microsatellite instability in colorectal cancer patients in different age groups.
Yiu R; Qiu H; Lee SH; García-Aguilar J
Dis Colon Rectum; 2005 Nov; 48(11):2061-9. PubMed ID: 16374936
[TBL] [Abstract][Full Text] [Related]
24. Methylation of estrogen receptor alpha and mutL homolog 1 in normal colonic mucosa: association with folate and vitamin B-12 status in subjects with and without colorectal neoplasia.
Al-Ghnaniem R; Peters J; Foresti R; Heaton N; Pufulete M
Am J Clin Nutr; 2007 Oct; 86(4):1064-72. PubMed ID: 17921385
[TBL] [Abstract][Full Text] [Related]
25. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
Herman JG; Umar A; Polyak K; Graff JR; Ahuja N; Issa JP; Markowitz S; Willson JK; Hamilton SR; Kinzler KW; Kane MF; Kolodner RD; Vogelstein B; Kunkel TA; Baylin SB
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6870-5. PubMed ID: 9618505
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer.
Niv Y
World J Gastroenterol; 2007 Mar; 13(12):1767-9. PubMed ID: 17465465
[TBL] [Abstract][Full Text] [Related]
27. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
[TBL] [Abstract][Full Text] [Related]
28. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer.
Hitchins MP; Lin VA; Buckle A; Cheong K; Halani N; Ku S; Kwok CT; Packham D; Suter CM; Meagher A; Stirzaker C; Clark S; Hawkins NJ; Ward RL
Cancer Res; 2007 Oct; 67(19):9107-16. PubMed ID: 17909015
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
31. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer.
Martínez-Urueña N; Macías L; Pérez-Cabornero L; Infante M; Lastra E; Cruz JJ; Miner C; González R; Durán M
Colorectal Dis; 2013 Mar; 15(3):e118-23. PubMed ID: 23374646
[TBL] [Abstract][Full Text] [Related]
32. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
33. Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis.
Miyakura Y; Sugano K; Konishi F; Fukayama N; Igarashi S; Kotake K; Matsui T; Koyama Y; Maekawa M; Nagai H
Genes Chromosomes Cancer; 2003 Jan; 36(1):17-25. PubMed ID: 12461746
[TBL] [Abstract][Full Text] [Related]
34. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.
Levine AJ; Phipps AI; Baron JA; Buchanan DD; Ahnen DJ; Cohen SA; Lindor NM; Newcomb PA; Rosty C; Haile RW; Laird PW; Weisenberger DJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):68-75. PubMed ID: 26512054
[TBL] [Abstract][Full Text] [Related]
36. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
Minoo P; Moyer MP; Jass JR
J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia.
Bai AH; Tong JH; To KF; Chan MW; Man EP; Lo KW; Lee JF; Sung JJ; Leung WK
Int J Cancer; 2004 Dec; 112(5):846-53. PubMed ID: 15386372
[TBL] [Abstract][Full Text] [Related]
38. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
40. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
